|
Volumn 9, Issue 10, 2006, Pages 682-685
|
Obesity Drug Development - CBI's 2nd Annual Summit. 27-28 July, 2006, Tysons Corner, VA, USA
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AGX 0104;
AGX 0119;
ANTIOBESITY AGENT;
CANNABINOID RECEPTOR ANTAGONIST;
CORTICOSTERONE;
DEXFENFLURAMINE;
ESTRONE;
EX 1350;
GHRELIN;
GLUCAGON LIKE PEPTIDE;
HEMOGLOBIN A1C;
HIGH DENSITY LIPOPROTEIN CHOLESTEROL;
HORMONE ANTAGONIST;
HORMONE RECEPTOR STIMULATING AGENT;
LEPTIN;
MELANOCORTIN 4 RECEPTOR;
METFORMIN;
OLEIC ACID;
PEPTIDE YY;
PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA ANTAGONIST;
PHENTERMINE;
PL 3233;
PLACEBO;
PRAMLINTIDE;
RIMONABANT;
SIBUTRAMINE;
SULFONYLUREA;
TETRAHYDROLIPSTATIN;
TRIACYLGLYCEROL;
UNCLASSIFIED DRUG;
UNINDEXED DRUG;
ADIPOCYTE;
ANXIETY DISORDER;
BARIATRIC SURGERY;
BEHAVIOR MODIFICATION;
CLINICAL TRIAL;
COMMERCIAL PHENOMENA;
CONFERENCE PAPER;
DIET THERAPY;
DIZZINESS;
DRUG APPROVAL;
DRUG EFFICACY;
DRUG INDICATION;
DRUG MARKETING;
DRUG POTENTIATION;
DRUG RESEARCH;
DRUG SCREENING;
DRUG STRUCTURE;
DRUG TARGETING;
ENERGY METABOLISM;
EXPERIMENTAL MODEL;
FINANCIAL MANAGEMENT;
GASTROINTESTINAL DISEASE;
HUMAN;
HUNGER;
HYPERTENSION;
INSOMNIA;
MALAISE;
MEDICAL RESEARCH;
METABOLIC RATE;
METABOLIC SYNDROME X;
MOUSE;
NAUSEA;
NON INSULIN DEPENDENT DIABETES MELLITUS;
NONHUMAN;
OBESITY;
RAT;
SATIETY;
TACHYCARDIA;
TREATMENT OUTCOME;
WAIST CIRCUMFERENCE;
WEIGHT REDUCTION;
ADIPOCYTES;
ANIMALS;
ANTI-OBESITY AGENTS;
DISEASE MODELS, ANIMAL;
DRUG DESIGN;
ENDOCANNABINOIDS;
ESTRONE;
FATTY ACIDS;
HUMANS;
OBESITY;
OLEIC ACIDS;
OXIDATION-REDUCTION;
PIPERIDINES;
PYRAZOLES;
RECEPTOR, CANNABINOID, CB1;
|
EID: 33750364939
PISSN: 13697056
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
Times cited : (1)
|
References (0)
|